2012
DOI: 10.1002/iub.1082
|View full text |Cite
|
Sign up to set email alerts
|

miRNAs in cardiac disease: Sitting duck or moving target?

Abstract: SummaryEmerging findings indicate that cells can produce both micro (mi)RNAs and their messenger (m)RNA targets in multiple processing variants in a tissue-and developmental stage-selective manner. Specifically, we find that cells accumulate a greater range of functional miRNAs than hitherto expected, whereas mRNAs with alternative 3 0 untranslated regions that include varying numbers of miRNA target sites are also seen to be common. This has important implications for both our understanding of miRNA function … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
3
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 62 publications
0
3
0
Order By: Relevance
“…MicroRNAs (miRNAs) are small, conserved, single-stranded, non-coding RNA molecules that bind to complementary sites located on the 3′-untranslated region (3′-UTR) of their target mRNAs, which thereby trigger either translational repression or RNA degradation ( Kataoka and Wang, 2014 ). MiRNAs are highly expressed in AFs, and play critical roles in the regulation of vascular cell growth, differentiation, apoptosis, and autophagy ( Hynes et al, 2012 ; De Rosa and Indolfi, 2015 ; Xu et al, 2016 ). Notably, microRNA-122 (miR-122) has been proposed as a biomarker of cardiovascular diseases such as atherosclerosis, acute coronary syndrome, and heart failure, which are all involved in arterial remodeling ( De Rosa and Indolfi, 2015 ; Xu et al, 2016 ).…”
Section: Introductionmentioning
confidence: 99%
“…MicroRNAs (miRNAs) are small, conserved, single-stranded, non-coding RNA molecules that bind to complementary sites located on the 3′-untranslated region (3′-UTR) of their target mRNAs, which thereby trigger either translational repression or RNA degradation ( Kataoka and Wang, 2014 ). MiRNAs are highly expressed in AFs, and play critical roles in the regulation of vascular cell growth, differentiation, apoptosis, and autophagy ( Hynes et al, 2012 ; De Rosa and Indolfi, 2015 ; Xu et al, 2016 ). Notably, microRNA-122 (miR-122) has been proposed as a biomarker of cardiovascular diseases such as atherosclerosis, acute coronary syndrome, and heart failure, which are all involved in arterial remodeling ( De Rosa and Indolfi, 2015 ; Xu et al, 2016 ).…”
Section: Introductionmentioning
confidence: 99%
“…[ 19 ] Highly proliferative cells have also been shown to have shorter 3’UTRs [ 20 ]. Longer UTRs have a greater number of cis-acting regulatory sites and so are likely under greater post-transcriptional control resulting in changes in protein level [ 6 , 21 , 22 ].…”
Section: Introductionmentioning
confidence: 99%
“…MicroRNAs have been shown to play an important role in many biological processes related to the cell cycle, such as cell development, proliferation, differentiation, metabolism, and apoptosis (9)(10)(11). Moreover, dysfunction of miRNAs has been associated with cancer (2,12), neurologic affections (13), and cardiovascular (14)(15)(16) or metabolic disorders (17).…”
mentioning
confidence: 99%